JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Figueroa, J V
Right arrow Articles by Buening, G M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Figueroa, J V
Right arrow Articles by Buening, G M
J Clin Microbiol. 1991 May; 29(5): 997-1003

In vitro inhibition of multiplication of Babesia bigemina by using monoclonal antibodies.

J V Figueroa and G M Buening

Department of Veterinary Microbiology, College of Veterinary Medicine, University of Missouri, Columbia 65211.

ABSTRACT

A panel of 21 monoclonal antibodies (MAb) against the erythrocytic stages of Babesia bigemina was produced. The 21 MAb could be divided into four distinct immunofluorescence groups on the basis of their patterns of binding to B. bigemina-infected erythrocytes. Nine MAb positive in the indirect immunofluorescent antibody test with acetone-fixed B. bigemina-infected erythrocytes were selected for purification and further characterization. The MAb were species specific, since they did not cross-react with B. bovis, but they were not stage specific. The purpose of this study was to evaluate the biological activity of B. bigemina-specific MAb in vitro. Three MAb inhibited the multiplication of B. bigemina in vitro as assessed by a lowered percentage of parasitized erythrocytes and by a decreased incorporation of [3H]hypoxanthine. These MAb are now being utilized to purify the correspondent parasite polypeptides, either native or recombinant, in order to test them as subunit immunogens.


J Clin Microbiol. 1991 May; 29(5): 997-1003




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 1991 by the American Society for Microbiology. All rights reserved.